Morgan Stanley, Microsoft and top stock pick

Analysts at Morgan Stanley reveal a top stock pick for 2025
Morgan Stanley. Investment firms have been impressed as well, and several reports that they recently issued expressed enthusiasm for the Menl
Morgan Stanley cuts Microsoft stock target, overweight rating amid concerns
Morgan Stanley (NYSE:MS) adjusted its outlook on shares of Microsoft stock (NASDAQ:MSFT), reducing the price target to $540 from the previous $548, yet reaffirming an Overweight rating. The decision comes amidst growing concerns among investors regarding various financial metrics and strategic partnerships.
Microsoft Stock Climbs 3% Despite Morgan Stanley's Price Target Cut
On Wednesday, Microsoft ( MSFT, Financial) shares grew nearly 3% despite Morgan Stanley lowering their price target from $548 to $540. However, the investment company kept its Overweight rating to reflect its belief in Microsoft's future growth while standing behind Microsoft's market leadership and new artificial intelligence technology prospects.
Morgan Stanley ups Palo Alto target, sees attractive entry point
Morgan Stanley raised the firm’s price target on Palo Alto Networks (PANW) to $230 from $223 and keeps an Overweight rating on the shares. The
Palo Alto Networks recent decline presents buying opportunity: Morgan Stanley
Palo Alto Networks' (NASDAQ:PANW) recent underperformance has created an attractive entry point for the cybersecurity firm, according to Morgan Stanley. Palo Alto Networks' shares increased 4% by noon trading on Tuesday.
Morgan Stanley Says Emerging Software Cycles Will Drive 2025 Growth — Here Are 3 Stocks to Bank on It
It’s been just over two years since ChatGPT introduced the world to the capabilities – and the potential – of generative AI.
Morgan Stanley's profit more than doubles on boost from dealmaking, stock sales
Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...
Morgan Stanley shares pop as dealmaking drives record revenue under first-year CEO
The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.
Morgan Stanley Remains a Buy on Ally Financial (ALLY)
Morgan Stanley analyst Jeffrey Adelson maintained a Buy rating on Ally Financial (ALLY – Research Report) today and set a price target of ...
Why Nvidia, Microsoft, Oracle, Arm, and Other AI Stocks Are Surging Wednesday
Shares of Nvidia, Microsoft, Oracle, and other AI-related companies surged Wednesday after the Trump administration’s ...
Morgan Stanley Profit Doubles as Stock Traders Notch Big Beat
Morgan Stanley’s traders beat analysts’ estimates in the fourth quarter, joining their other Wall Street rivals in reporting ...
Morningstar1d
Morgan Stanley Inst Growth I
But these qualities are less prevalent here than at Morgan Stanley Advantage MPAIX ... over in mid-2004 and was named Morningstar Domestic Stock Fund Manager of 2013. He works with around two ...
Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why
Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate ...
Stock market today: Wall Street begins Trump’s second term with gains
U.S. stock indexes are drifting higher following a mostly encouraging batch of profit reports from big companies.
Johnson & Johnson (JNJ) Receives a Hold from Morgan Stanley
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a ...